The advances of interventional therapy and coronary artery bypass grafting for left main and/or triple vessel disease of coronary artery disease
Yang Kun
Deng Yongzhi
Abstract:Coronary artery bypass grafting(CABG)has been the preferred choice of treatment for left main coronary ar-tery disease(LMCAD)and triple vessel disease(TVD)for quite long time.In recent years,due to the rapid development of endo-luminal imaging technology and the introduction of novel coronary artery stents,percutaneous coronary intervention(PCI)has become one of the alternative treatment choice for LMCAD and TVD as the long-term patency and target vessel revascularisa-tion rates have been improved compared with the previous ones.But there is still no international consensus on therapeutic deci-sion-making for LMCAD and TVD lesions.This paper summarizes the available evidence on the long-term outcomes of these two therapeutic strategies for LMCAD and TVD lesions in order to aid clinical decision-making and improve the therapeutic ef-fect.
Keywords:Coronary artery diseaseLeft main coronary artery diseaseMultivessel coronary artery diseaseCoronary artery bypass graftingPercutaneous coronary intervention
Publication Date:2023-12-28
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:5( 376-380 )
Chinese Journal of Extracorporeal Circulation

Chinese Journal of Extracorporeal Circulation

ISTIC
ISSN:1672-1403
Year, Vol.(Issue):2023,21(6)